Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progression

Nucleic Acids Research

Volumn 30, Issue 11, 2002, Pages 2565-2574

  Stewart, Delisha A ^a   Xu, Xiaohou ^b   Thomas, Shelia D ^b   Miller, Donald M ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE; ALPHA ACTIN; ANTIINFECTIVE AGENT; ANTIMITOTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BCR ABL PROTEIN; BETA ACTIN; CHLORAMBUCIL; CISPLATIN; COMPLEMENTARY DNA; CYCLINE; FOMIVIRSEN; KI 67 ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY; MYC PROTEIN; OLIGONUCLEOTIDE; OLIGONUCLEOTIDE E1C; OLIGONUCLEOTIDE E2C; OLIGONUCLEOTIDE E3C; PHOSPHOROTHIOIC ACID; POLYCLONAL ANTIBODY; PROTEIN BCL 2; PROTEIN C MYB; PROTEIN P21; PROTEIN P53; PSORALEN DERIVATIVE; PURINE; RAS PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA HYBRIDIZATION; DRUG EFFICACY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SEQUENCE; GENE TARGETING; HYDROGEN BOND; IMMUNOFLUORESCENCE; IN VIVO STUDY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN NUCLEIC ACID INTERACTION; RNA STRUCTURE; TOXICITY TESTING; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALIA; MURINAE;

EID: 0036606156     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/30.11.2565     Document Type: Article

References (50)

1. Gene expression in melanoma cell lines and cultured melanocytes: Correlation between levels of c-src-1, c-myc and p53
2. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin
3. C-myc oncogene expression in human melanoma and its relationship with tumour antigenicity
4. Immunohistochemical expression of c-myc oncogene, heat shock protein 70 and HLA-DR molecules in malignant cutaneous melanoma
5. Influence of increased c-myc expression on the growth characteristics of human melanoma
6. Inhibition of nuclear protein binding to two sites in the murine c-myc promoter by intermolecular triplex formation
7. Transgenic mouse models in carcinogenesis: Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis
8. Myc function and regulation
9. Psoralen-modified clamp-forming antisense oligonucleotides reduce cellular c-myc protein expression and B16-F0 proliferation
10. Antisense oligonucleotides: Towards clinical trials
11. In vivo studies with antisense oligonucleotides
12. Antitumor effects of antisense phosphorothioate c-myc oligodeoxynucleotides: A question of mechanism
13. The status of oncogenes in malignant melanoma
14. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma
15. The human myc gene family: Structure and activity of L-myc and an L-myc pseudogene
16. New light on Myc and Myb. Myc
17. Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex
18. Pharmacokinetics, biodistribution and stability of oligodeoxynucleotide phosphorothioates in mice
19. Pharmacokinetics of antisense oligonucleotides
20. Circular oligonucleotides: New concepts in oligonucleotide design
21. Oligonucleotide clamps arrest DNA synthesis on a single-stranded DNA target
22. Spectroscopic and calorimetric investigation on the DNA triplex formed by d(CTCTTCTTTCTTTCTTTCTTCTC) and d(GAGAAGAAAGA) at acidic pH
23. Formation of a three-stranded polynucleotide molecule
24. Antisense oligonucleotides: A new therapeutic principle
25. Specific regulation of gene expression by antisense, sense and antigene nucleic acids
26. Inhibition of HIV-1 reverse transcription by triple-helix forming oligonucleotides with viral RNA
27. Targeting pyrimidine single strands by triplex formation: Structural optimization of binding
28. Isolation and characterization of an infectious molecular clone of the MN strain of HIV-1
29. Bimolecular DNA triplexes: Duplex extensions show implications for H-form DNA stability
30. Single-stranded DNA as a target for triplex formation
31. Stabilities of nucleotide loops bridging the pyrimidine strands in DNA pyrimidine·purine·pyrimidine triplexes: Special stability of the CTTTG loop
32. Oligo(alpha-deoxynucleotide)s covalently linked to intercalating agents: Differential binding to ribo- and deoxyribopolynucleotides and stability towards nuclease digestion
33. A comparison of vinblastine, bleomycin and cisplatin (VBD) with dacarbazine (DTIC) in metastatic melanoma
34. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and in mice
35. Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis
36. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide
37. Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide
38. Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model
39. Antisense strategy in hematological malignancies
40. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice
41. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides
42. Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes
43. Inhibition of telomerase by 2′-O-(2-methoxyethyl) RNA oligomers: Effect of length, phosphorothioate substitution and time inside cells
44. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression
45. Proteins of the Myc network: Essential regulators of cell growth and differentiation
46. Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma
47. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate
48. Targeting of single-stranded DNA and RNA containing adjacent pyrimidine and purine tracts by triple helix formation with circular and clamp oligonucleotides